To the full analysis
Apotex Health stock: dividend
APTX.TOApotex Health paid $0.04 per share over the last twelve months, 0.16% on the price.
Daily figure as of 13 Nov 2026
Dividend yield over the last 12 months
0.16%
$0.04 per share over 12 months
Dividend per share 2025
$3.36
paid in fiscal 2025
297%
more than earnings, the rest comes from reserves
$1.39
does not cover the dividend of $3.36
Raised in a row
0 years
Years with a higher annual dividend than the year before
Growth 5 years
no data
per year, from the last twelve months, without special dividends
Growth 10 years
no data
per year, from the last twelve months, without special dividends
The amounts for the last 12 months and paid in fiscal 2025 differ if the company has raised or cut its dividend since then.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
Last ex-dividend date
15 Sep 2026
$0.0421, paid 30 Sep 2026
Next ex-dividend date
not announced yet
Frequency
irregular
All 1 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 15 Sep 2026 | 30 Sep 2026 | $0.0421 |
Dividend development
Dividend per share
Payout ratio
- of earnings
- of free cash flow
Figures as a table
| Year | Dividend per share | Earnings per share |
|---|---|---|
| 2024 | $0.50 | $0.46 |
| 2025 | $3.36 | $1.13 |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CA$1.4249)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Strong
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.